La Riche, France

Christophe Vandier

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Christophe Vandier: Pioneering Cancer Treatment Innovations

Introduction

Christophe Vandier, an innovative inventor based in La Riche, France, has made significant contributions to the field of cancer treatment through his research and development of novel therapeutic compounds. With a focus on ion channel inhibitors, his work stands out in the ongoing quest for effective cancer therapies.

Latest Patents

Vandier holds a patent for "Ion channel inhibitor compounds for cancer treatment." This invention encompasses a compound represented by a general formula (I), showcasing the potential for a new class of drugs aimed at combating cancer by targeting ion channels.

Career Highlights

Throughout his career, Vandier has been associated with reputable institutions, including the Centre National de la Recherche Scientifique and the University of Orléans. His academic and research affiliations have provided him with a robust platform to advance his innovative ideas and contribute to scientific knowledge.

Collaborations

In his professional journey, Vandier has collaborated with notable coworkers such as Sylvain Routier and Frédéric Buron. These collaborations have played a pivotal role in refining his inventions and expanding the impact of his research in the scientific community.

Conclusion

Christophe Vandier's dedication to innovation in cancer treatment through his patent for ion channel inhibitor compounds marks him as a significant figure in the realm of medical research. His contributions continue to inspire advancements in the fight against cancer, reflecting the critical role inventors play in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…